mPFC-rTMS for patients with insomnia disorder using resting-state functional magnetic resonance imaging: a protocol for a randomized controlled trial

Jingjing Sun,Guohai Li,Danwei Zhang,Kaimo Ding,Jun Zhu,Si Luo,Wenyue Xu,Zhoubing Wang
DOI: https://doi.org/10.1186/s13063-022-06934-1
IF: 2.728
2022-12-13
Trials
Abstract:Insomnia is the most common sleep disorder. Repetitive transcranial magnetic stimulation (rTMS) is safe and effective for insomnia disorder (ID). Convergent evidence show that the medial prefrontal cortex (mPFC) may be involved in the regulation of sleep and awakening at the cortical level and may serve as a potential target of rTMS in the treatment of ID. The purpose of this clinical trial is to study the efficacy of mPFC-rTMS in the treatment ID and explore the neural mechanism using resting-state functional magnetic resonance imaging (fMRI).
medicine, research & experimental
What problem does this paper attempt to address?